Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Bluefish Pharmaceuticals AB (publ)

Closing information (x1000 SEK)

Closing information 2024/04 (consolidated) 2023/04 (consolidated) 2021/12 (consolidated)
Turnover 484,778 More Arrow 540,097 Less Arrow 385,500
Financial expenses 29,463 More Arrow 41,154 Less Arrow 15,398
Earnings before taxes 32,576 Less Arrow -90,170 More Arrow -18,974
EBITDA 47,569 Less Arrow -27,543 More Arrow 17,604
Total assets 588,902 Less Arrow 540,718 More Arrow 568,148
Current assets 463,129 Less Arrow 411,429 More Arrow 457,885
Current liabilities 303,608 Less Arrow 202,590 More Arrow 457,003
Equity capital 44,996 Less Arrow -41,649 More Arrow 88,697
- share capital 21,584 Equal arrow 21,584 Equal arrow 21,584
Employees (average) 126 More Arrow 128 Less Arrow 124

Financial ratios

Fiscal year 2024/04 (consolidated) 2023/04 (consolidated) 2021/12 (consolidated)
Solvency 7.6% Less Arrow -7.7% More Arrow 15.6%
Turnover per employee 3,847 More Arrow 4,220 Less Arrow 3,109
Profit as a percentage of turnover 6.7% Less Arrow -16.7% More Arrow -4.9%
Return on assets (ROA) 10.5% Less Arrow -9.1% More Arrow -0.6%
Current ratio 152.5% More Arrow 203.1% Less Arrow 100.2%
Return on equity (ROE) 72.4% More Arrow 216.5% Less Arrow -21.4%
Change turnover -55,319 More Arrow 154,597 Less Arrow -28,918
Change turnover % -10% More Arrow 40% Less Arrow -7%
Chg. No. of employees -2 More Arrow 4 Less Arrow -5
Chg. No. of employees % -2% More Arrow 3% Less Arrow -4%

Total value of public sale

Fiscal year 2024/04 (consolidated) 2023/04 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.